4th Quarter - Report

WALGREEN COMPANY for WALGREEN COMPANY

Period 4th Quarter 2024 Filed Jan 20, 2025 Signed by G. Joel Baise, Director, Government Relations

Official filing
Firm
WALGREEN COMPANY
Client
WALGREEN COMPANY
Income
—
Expenses
$920,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act: Issues related to access to pharmacist services. Issues related to increasing participation and diversity in clinical trials. Issues related to pharmacy services on military treatment facilities.

LobbyistCovered position, as disclosed
ISAAC FORDJOUR —
MADELINE KAY HODGE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 2477 (118th), H.R. 1770 (118th)

Consumer Issues/Safety/Products CSP

H.R. 189/S.140 - Combatting Organized Retail Crime Act: Issues related to preventing organized retail crime.

LobbyistCovered position, as disclosed
ISAAC FORDJOUR —
MADELINE KAY HODGE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 189 (118th), S. 140 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.